Verapamil as Therapy for Children and Young Adults With Dravet Syndrome
Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
This study will assess how well the drug verapamil can improve control of seizures and
dysautonomia symptoms in children and young adults diagnosed with Dravet syndrome. The safety
of verapamil when given with all concomitant medications will also be assessed.
Phase:
Phase 2
Details
Lead Sponsor:
Beverly S. Wical, M.D. Gillette Children's Specialty Healthcare
Collaborators:
Ann & Robert H Lurie Children's Hospital of Chicago Dartmouth-Hitchcock Medical Center Mayo Clinic